| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C STXBP5L TBC1D3B TBC1D3K TBC1D3F | 2.41e-13 | 279 | 41 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C STXBP5L TBC1D3B TBC1D3K TBC1D3F | 2.55e-10 | 507 | 41 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C STXBP5L TBC1D3B TBC1D3K TBC1D3F | 2.55e-10 | 507 | 41 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G GPR158 TBC1D3C STXBP5L TBC1D3B TBC1D3K TBC1D3F | 3.49e-10 | 656 | 41 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | CDKN2A TBC1D3E IRS1 TBC1D3 TBC1D3L TBC1D3H BSN TBC1D3I TBC1D3D TBC1D3G GPR158 TBC1D3C STXBP5L TBC1D3B TBC1D3K TBC1D3F | 7.23e-09 | 1418 | 41 | 16 | GO:0030234 |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G GPR158 TBC1D3C STXBP5L TBC1D3B TBC1D3K TBC1D3F | 6.17e-07 | 1233 | 41 | 13 | GO:0140677 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.50e-06 | 303 | 41 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.95e-05 | 37 | 41 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.32e-04 | 562 | 41 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.07e-03 | 98 | 41 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.17e-03 | 1160 | 41 | 8 | GO:0030674 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.25e-03 | 127 | 41 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 2.90e-03 | 39 | 41 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.75e-03 | 739 | 41 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.02e-03 | 46 | 41 | 2 | GO:0030020 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 4.92e-03 | 51 | 41 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 5.65e-03 | 1356 | 41 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 5.70e-03 | 55 | 41 | 2 | GO:0061733 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.09e-16 | 109 | 40 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.66e-13 | 244 | 40 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.68e-11 | 335 | 40 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | CDKN2A TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.06e-10 | 499 | 40 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | CDKN2A TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.10e-08 | 878 | 40 | 12 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CDKN2A NCOA3 TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B HNRNPK TBC1D3K TBC1D3F | 2.33e-07 | 1430 | 40 | 14 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CDKN2A TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.37e-07 | 1028 | 40 | 12 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.38e-05 | 29 | 40 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 7.36e-05 | 42 | 40 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 8.47e-05 | 44 | 40 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 9.10e-05 | 237 | 40 | 5 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.00e-04 | 242 | 40 | 5 | GO:0098727 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.37e-04 | 136 | 40 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.56e-04 | 54 | 40 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 1.62e-04 | 142 | 40 | 4 | GO:0034728 | |
| GeneOntologyBiologicalProcess | neuron-neuron synaptic transmission | 2.39e-04 | 12 | 40 | 2 | GO:0007270 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.74e-04 | 896 | 40 | 8 | GO:0006325 | |
| GeneOntologyBiologicalProcess | cell junction organization | 4.80e-04 | 974 | 40 | 8 | GO:0034330 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 4.86e-04 | 976 | 40 | 8 | GO:0099536 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 4.97e-04 | 741 | 40 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 5.02e-04 | 191 | 40 | 4 | GO:0072331 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 5.68e-04 | 999 | 40 | 8 | GO:0071824 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 6.61e-04 | 88 | 40 | 3 | GO:0006289 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 7.53e-04 | 92 | 40 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 7.55e-04 | 213 | 40 | 4 | GO:2000045 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 8.26e-04 | 95 | 40 | 3 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 8.26e-04 | 95 | 40 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 8.27e-04 | 22 | 40 | 2 | GO:0006337 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 9.05e-04 | 98 | 40 | 3 | GO:1902099 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 9.41e-04 | 226 | 40 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 9.59e-04 | 100 | 40 | 3 | GO:0007091 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 9.85e-04 | 24 | 40 | 2 | GO:0032986 | |
| GeneOntologyBiologicalProcess | apoptotic DNA fragmentation | 9.85e-04 | 24 | 40 | 2 | GO:0006309 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.04e-03 | 103 | 40 | 3 | GO:0044784 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 1.20e-03 | 108 | 40 | 3 | GO:0035019 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.29e-03 | 246 | 40 | 4 | GO:1902806 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.30e-03 | 111 | 40 | 3 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 1.55e-03 | 118 | 40 | 3 | GO:0046928 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 1.58e-03 | 119 | 40 | 3 | GO:1901796 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.63e-03 | 663 | 40 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.64e-03 | 664 | 40 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.72e-03 | 266 | 40 | 4 | GO:0045619 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.72e-03 | 266 | 40 | 4 | GO:0033044 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 1.84e-03 | 271 | 40 | 4 | GO:0000082 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.89e-03 | 931 | 40 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.89e-03 | 931 | 40 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.92e-03 | 685 | 40 | 6 | GO:0050808 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.98e-03 | 939 | 40 | 7 | GO:0099537 | |
| GeneOntologyCellularComponent | bBAF complex | 8.32e-07 | 10 | 41 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.21e-06 | 96 | 41 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | brahma complex | 2.51e-06 | 14 | 41 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | chromatin | ETV1 CDKN2A NCOA3 SMARCD2 RHOXF2B ARID1B ARID1A ATRX RHOXF2 CECR2 HNRNPK SS18L1 KAT6A | 2.88e-06 | 1480 | 41 | 13 | GO:0000785 |
| GeneOntologyCellularComponent | nBAF complex | 3.85e-06 | 16 | 41 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | ATPase complex | 5.19e-06 | 129 | 41 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.74e-05 | 30 | 41 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | npBAF complex | 3.36e-04 | 14 | 41 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.17e-03 | 1377 | 41 | 9 | GO:0140513 | |
| HumanPheno | Aspiration pneumonia | 3.39e-05 | 95 | 11 | 4 | HP:0011951 | |
| HumanPheno | Sandal gap | 3.53e-05 | 96 | 11 | 4 | HP:0001852 | |
| HumanPheno | Gastrointestinal dysmotility | 7.45e-05 | 116 | 11 | 4 | HP:0002579 | |
| HumanPheno | Abnormal gastrointestinal motility | 7.96e-05 | 118 | 11 | 4 | HP:0030895 | |
| HumanPheno | Myopia | 1.39e-04 | 447 | 11 | 6 | HP:0000545 | |
| HumanPheno | Abnormality of upper lip vermillion | 1.72e-04 | 464 | 11 | 6 | HP:0011339 | |
| HumanPheno | Conical tooth | 1.85e-04 | 55 | 11 | 3 | HP:0000698 | |
| HumanPheno | Thyroid carcinoma | 2.06e-04 | 57 | 11 | 3 | HP:0002890 | |
| HumanPheno | Neoplasm of the endocrine system | 2.30e-04 | 155 | 11 | 4 | HP:0100568 | |
| HumanPheno | Abnormal consumption behavior | 2.32e-04 | 299 | 11 | 5 | HP:0040202 | |
| HumanPheno | Thin eyebrow | 2.40e-04 | 60 | 11 | 3 | HP:0045074 | |
| HumanPheno | Broad nasal tip | 2.54e-04 | 159 | 11 | 4 | HP:0000455 | |
| HumanPheno | Abnormal stomach morphology | 2.61e-04 | 742 | 11 | 7 | HP:0002577 | |
| HumanPheno | Pneumonia | 2.80e-04 | 311 | 11 | 5 | HP:0002090 | |
| HumanPheno | Neoplasm of the gastrointestinal tract | 2.88e-04 | 313 | 11 | 5 | HP:0007378 | |
| HumanPheno | Hypoplastic fifth fingernail | 3.80e-04 | 14 | 11 | 2 | HP:0008398 | |
| HumanPheno | Paradoxical increased cortisol secretion on dexamethasone suppression test | 5.00e-04 | 16 | 11 | 2 | HP:0003466 | |
| HumanPheno | Increased urinary cortisol level | 5.00e-04 | 16 | 11 | 2 | HP:0012030 | |
| HumanPheno | Prominent eyelashes | 5.67e-04 | 17 | 11 | 2 | HP:0011231 | |
| HumanPheno | Oral aversion | 5.67e-04 | 17 | 11 | 2 | HP:0012523 | |
| HumanPheno | Bifid nasal tip | 6.37e-04 | 18 | 11 | 2 | HP:0000456 | |
| HumanPheno | Intellectual disability, severe | 6.38e-04 | 371 | 11 | 5 | HP:0010864 | |
| HumanPheno | Digestive system neoplasm | 6.63e-04 | 374 | 11 | 5 | HP:0034930 | |
| HumanPheno | Hypoplastic fifth toenail | 7.11e-04 | 19 | 11 | 2 | HP:0011937 | |
| HumanPheno | Abnormal urine hormone level | 7.11e-04 | 19 | 11 | 2 | HP:0012029 | |
| HumanPheno | Neoplasm of the thyroid gland | 7.19e-04 | 87 | 11 | 3 | HP:0100031 | |
| HumanPheno | Abnormal nasal tip morphology | 7.67e-04 | 386 | 11 | 5 | HP:0000436 | |
| HumanPheno | Hirsutism | 8.20e-04 | 216 | 11 | 4 | HP:0001007 | |
| HumanPheno | Coxa valga | 8.47e-04 | 92 | 11 | 3 | HP:0002673 | |
| HumanPheno | Macrostomia | 8.79e-04 | 220 | 11 | 4 | HP:0000181 | |
| HumanPheno | Wide mouth | 8.79e-04 | 220 | 11 | 4 | HP:0000154 | |
| HumanPheno | Intermittent diarrhea | 9.57e-04 | 22 | 11 | 2 | HP:0002254 | |
| MousePheno | premature death | 3.45e-05 | 1051 | 24 | 9 | MP:0002083 | |
| MousePheno | abnormal synaptic acetylcholine release | 5.90e-05 | 7 | 24 | 2 | MP:0004836 | |
| Domain | TBC | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.63e-18 | 49 | 40 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.09e-17 | 53 | 40 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.63e-17 | 55 | 40 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.63e-17 | 55 | 40 | 10 | IPR000195 |
| Domain | BAF250_C | 4.47e-06 | 2 | 40 | 2 | IPR033388 | |
| Domain | BAF250_C | 4.47e-06 | 2 | 40 | 2 | PF12031 | |
| Domain | BAF250/Osa | 4.47e-06 | 2 | 40 | 2 | IPR021906 | |
| Domain | - | 4.61e-04 | 15 | 40 | 2 | 1.10.150.60 | |
| Domain | ARID | 4.61e-04 | 15 | 40 | 2 | PF01388 | |
| Domain | BRIGHT | 4.61e-04 | 15 | 40 | 2 | SM00501 | |
| Domain | ARID_dom | 4.61e-04 | 15 | 40 | 2 | IPR001606 | |
| Domain | ARID | 4.61e-04 | 15 | 40 | 2 | PS51011 | |
| Domain | Znf_FYVE_PHD | 3.81e-03 | 147 | 40 | 3 | IPR011011 | |
| Domain | Collagen | 1.43e-02 | 85 | 40 | 2 | PF01391 | |
| Domain | Collagen | 1.43e-02 | 85 | 40 | 2 | IPR008160 | |
| Domain | - | 1.52e-02 | 449 | 40 | 4 | 3.30.40.10 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 9.62e-13 | 99 | 33 | 9 | M46448 |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 7.49e-07 | 31 | 33 | 4 | M39522 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.56e-06 | 95 | 33 | 5 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.62e-06 | 42 | 33 | 4 | M48237 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.54e-05 | 137 | 33 | 5 | M48232 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.10e-05 | 29 | 33 | 3 | M48076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 7.27e-05 | 35 | 33 | 3 | M47969 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 7.40e-05 | 97 | 33 | 4 | M48262 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 8.60e-05 | 37 | 33 | 3 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.22e-04 | 142 | 33 | 4 | M48257 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.62e-04 | 65 | 33 | 3 | M39682 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.77e-04 | 74 | 33 | 3 | M160 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 7.89e-04 | 78 | 33 | 3 | M27234 | |
| Pathway | WP_TYPE_II_DIABETES_MELLITUS | 1.19e-03 | 22 | 33 | 2 | M39658 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.19e-03 | 22 | 33 | 2 | MM1370 | |
| Pathway | WP_THERMOGENESIS | 2.02e-03 | 108 | 33 | 3 | M39746 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 2.13e-03 | 110 | 33 | 3 | M48043 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.40e-33 | 11 | 41 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 3.13e-12 | 74 | 41 | 7 | 16625196 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 6.08e-09 | 4 | 41 | 3 | 12359748 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 8406013 | ||
| Pubmed | 1.39e-08 | 65 | 41 | 5 | 26655900 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 12604796 | ||
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 8471161 | ||
| Pubmed | 3.03e-08 | 157 | 41 | 6 | 30186101 | ||
| Pubmed | 1.81e-07 | 10 | 41 | 3 | 12665591 | ||
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 23785148 | ||
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 6.85e-07 | 15 | 41 | 3 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 6.85e-07 | 15 | 41 | 3 | 17920018 | |
| Pubmed | 6.88e-07 | 638 | 41 | 8 | 31182584 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 1.02e-06 | 17 | 41 | 3 | 12368262 | |
| Pubmed | 1.02e-06 | 17 | 41 | 3 | 11078522 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 1.23e-06 | 18 | 41 | 3 | 23698369 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 34386776 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23202128 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12087094 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33890484 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 1.36e-06 | 2 | 41 | 2 | 24562383 | |
| Pubmed | ETV1 positively regulates transcription of tumor suppressor ARF. | 1.36e-06 | 2 | 41 | 2 | 24157551 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 1.36e-06 | 2 | 41 | 2 | 37611161 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 1.36e-06 | 2 | 41 | 2 | 29890703 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 24788099 | ||
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 1.36e-06 | 2 | 41 | 2 | 16496311 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 1.36e-06 | 2 | 41 | 2 | 28967863 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33052929 | ||
| Pubmed | NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. | 1.36e-06 | 2 | 41 | 2 | 17805331 | |
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 1.36e-06 | 2 | 41 | 2 | 16465597 | |
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 1.36e-06 | 2 | 41 | 2 | 27562491 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 1.36e-06 | 2 | 41 | 2 | 16414020 | |
| Pubmed | 1.45e-06 | 19 | 41 | 3 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 1.45e-06 | 19 | 41 | 3 | 12110891 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 2.65e-06 | 23 | 41 | 3 | 30962207 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 2.65e-06 | 23 | 41 | 3 | 8804307 | |
| Pubmed | 2.85e-06 | 83 | 41 | 4 | 28794006 | ||
| Pubmed | 3.03e-06 | 24 | 41 | 3 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 3.03e-06 | 24 | 41 | 3 | 10078207 | |
| Pubmed | 3.03e-06 | 24 | 41 | 3 | 12215535 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.38e-06 | 351 | 41 | 6 | 38297188 | |
| Pubmed | 3.88e-06 | 26 | 41 | 3 | 10778858 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 33432679 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 21647563 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 4.06e-06 | 3 | 41 | 2 | 26716708 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18562707 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28942143 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 4.06e-06 | 3 | 41 | 2 | 21030649 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24307508 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18077458 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 4.06e-06 | 3 | 41 | 2 | 22426308 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24382590 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 32678261 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22859932 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 38457226 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 34512623 | ||
| Pubmed | 4.36e-06 | 27 | 41 | 3 | 29374058 | ||
| Pubmed | 4.88e-06 | 28 | 41 | 3 | 30037996 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 4.88e-06 | 28 | 41 | 3 | 12192000 | |
| Pubmed | 5.44e-06 | 29 | 41 | 3 | 19279220 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.02e-06 | 220 | 41 | 5 | 35785414 | |
| Pubmed | 6.04e-06 | 30 | 41 | 3 | 31043422 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 6.93e-06 | 398 | 41 | 6 | 35016035 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 25605372 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 22348058 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 31259687 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 28863077 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 8.12e-06 | 4 | 41 | 2 | 15170388 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 29719265 | ||
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 8.12e-06 | 4 | 41 | 2 | 11988099 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 15707895 | ||
| Pubmed | 9.69e-06 | 35 | 41 | 3 | 32504627 | ||
| Pubmed | 1.15e-05 | 37 | 41 | 3 | 24335282 | ||
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 1.35e-05 | 5 | 41 | 2 | 12672490 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 12200431 | ||
| Pubmed | MOZ and BMI1 act synergistically to maintain hematopoietic stem cells. | 1.35e-05 | 5 | 41 | 2 | 27773671 | |
| Pubmed | Expression of a novel homeobox gene Ehox in trophoblast stem cells and pharyngeal pouch endoderm. | 1.35e-05 | 5 | 41 | 2 | 14648851 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 38489371 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.46e-05 | 40 | 41 | 3 | 34585037 | |
| Pubmed | 1.56e-05 | 268 | 41 | 5 | 33640491 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 2.03e-05 | 6 | 41 | 2 | 25081545 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 23540691 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 14747462 | ||
| Pubmed | 3.82e-05 | 55 | 41 | 3 | 35945219 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 23556151 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 4.86e-05 | 9 | 41 | 2 | 20086098 | |
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 19176441 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 37805104 | ||
| Pubmed | 5.22e-05 | 61 | 41 | 3 | 20305087 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 6.07e-05 | 10 | 41 | 2 | 16751102 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 15922553 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 6.07e-05 | 10 | 41 | 2 | 23129809 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 21972064 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 18003620 | ||
| Pubmed | 8.57e-05 | 72 | 41 | 3 | 24509480 | ||
| Pubmed | Arid1a regulates bladder urothelium formation and maintenance. | 8.88e-05 | 12 | 41 | 2 | 35283102 | |
| Interaction | CRX interactions | 2.50e-08 | 254 | 39 | 8 | int:CRX | |
| Interaction | PAX8 interactions | 6.85e-08 | 111 | 39 | 6 | int:PAX8 | |
| Interaction | TBR1 interactions | 7.63e-08 | 113 | 39 | 6 | int:TBR1 | |
| Interaction | TBXT interactions | 8.92e-08 | 116 | 39 | 6 | int:TBXT | |
| Interaction | FEV interactions | 1.11e-07 | 203 | 39 | 7 | int:FEV | |
| Interaction | PAX7 interactions | 1.33e-07 | 124 | 39 | 6 | int:PAX7 | |
| Interaction | GCM1 interactions | 1.98e-07 | 68 | 39 | 5 | int:GCM1 | |
| Interaction | ERG interactions | 2.10e-07 | 223 | 39 | 7 | int:ERG | |
| Interaction | ETV4 interactions | 2.14e-07 | 69 | 39 | 5 | int:ETV4 | |
| Interaction | SOX7 interactions | 5.09e-07 | 82 | 39 | 5 | int:SOX7 | |
| Interaction | KLF4 interactions | 5.99e-07 | 160 | 39 | 6 | int:KLF4 | |
| Interaction | FOXI1 interactions | 9.05e-07 | 92 | 39 | 5 | int:FOXI1 | |
| Interaction | TLX1 interactions | 1.01e-06 | 175 | 39 | 6 | int:TLX1 | |
| Interaction | SOX17 interactions | 1.06e-06 | 95 | 39 | 5 | int:SOX17 | |
| Interaction | SOX9 interactions | 1.18e-06 | 97 | 39 | 5 | int:SOX9 | |
| Interaction | SP7 interactions | 1.69e-06 | 304 | 39 | 7 | int:SP7 | |
| Interaction | MYOD1 interactions | 1.84e-06 | 194 | 39 | 6 | int:MYOD1 | |
| Interaction | BRD9 interactions | 2.98e-06 | 117 | 39 | 5 | int:BRD9 | |
| Interaction | ETS1 interactions | 3.51e-06 | 121 | 39 | 5 | int:ETS1 | |
| Interaction | PAX9 interactions | 4.99e-06 | 130 | 39 | 5 | int:PAX9 | |
| Interaction | TEX13B interactions | 7.47e-06 | 20 | 39 | 3 | int:TEX13B | |
| Interaction | NFIB interactions | 7.68e-06 | 142 | 39 | 5 | int:NFIB | |
| Interaction | BICRA interactions | 8.41e-06 | 67 | 39 | 4 | int:BICRA | |
| Interaction | HNF4A interactions | 1.37e-05 | 275 | 39 | 6 | int:HNF4A | |
| Interaction | EGR2 interactions | 1.89e-05 | 171 | 39 | 5 | int:EGR2 | |
| Interaction | STK11IP interactions | 1.97e-05 | 83 | 39 | 4 | int:STK11IP | |
| Interaction | SMAD3 interactions | 2.10e-05 | 447 | 39 | 7 | int:SMAD3 | |
| Interaction | ARID1B interactions | 2.23e-05 | 177 | 39 | 5 | int:ARID1B | |
| Interaction | SS18 interactions | 2.48e-05 | 88 | 39 | 4 | int:SS18 | |
| Interaction | LHX3 interactions | 2.76e-05 | 185 | 39 | 5 | int:LHX3 | |
| Interaction | FOS interactions | 2.78e-05 | 312 | 39 | 6 | int:FOS | |
| Interaction | GATA3 interactions | 2.91e-05 | 187 | 39 | 5 | int:GATA3 | |
| Interaction | SOX10 interactions | 2.96e-05 | 92 | 39 | 4 | int:SOX10 | |
| Interaction | NFIA interactions | 2.98e-05 | 188 | 39 | 5 | int:NFIA | |
| Interaction | DPF3 interactions | 3.36e-05 | 95 | 39 | 4 | int:DPF3 | |
| Interaction | DPF1 interactions | 3.36e-05 | 95 | 39 | 4 | int:DPF1 | |
| Interaction | BCL7B interactions | 3.36e-05 | 95 | 39 | 4 | int:BCL7B | |
| Interaction | KLF5 interactions | 3.55e-05 | 195 | 39 | 5 | int:KLF5 | |
| Interaction | SS18L1 interactions | 3.79e-05 | 98 | 39 | 4 | int:SS18L1 | |
| Interaction | GATA2 interactions | 3.91e-05 | 199 | 39 | 5 | int:GATA2 | |
| Interaction | LHX1 interactions | 4.61e-05 | 103 | 39 | 4 | int:LHX1 | |
| Interaction | NFIC interactions | 5.05e-05 | 210 | 39 | 5 | int:NFIC | |
| Interaction | SMARCD3 interactions | 5.35e-05 | 107 | 39 | 4 | int:SMARCD3 | |
| Interaction | ACTG1 interactions | 5.49e-05 | 520 | 39 | 7 | int:ACTG1 | |
| Interaction | PAX6 interactions | 6.77e-05 | 366 | 39 | 6 | int:PAX6 | |
| Interaction | RBM41 interactions | 6.79e-05 | 41 | 39 | 3 | int:RBM41 | |
| Interaction | BCL7C interactions | 7.09e-05 | 115 | 39 | 4 | int:BCL7C | |
| Interaction | MLLT1 interactions | 9.21e-05 | 123 | 39 | 4 | int:MLLT1 | |
| Interaction | BCL7A interactions | 9.21e-05 | 123 | 39 | 4 | int:BCL7A | |
| Interaction | CIMIP2A interactions | 1.01e-04 | 8 | 39 | 2 | int:CIMIP2A | |
| Interaction | TBC1D3F interactions | 1.01e-04 | 8 | 39 | 2 | int:TBC1D3F | |
| Interaction | PBRM1 interactions | 1.33e-04 | 258 | 39 | 5 | int:PBRM1 | |
| Interaction | PHF10 interactions | 1.48e-04 | 139 | 39 | 4 | int:PHF10 | |
| Interaction | SOX15 interactions | 1.56e-04 | 141 | 39 | 4 | int:SOX15 | |
| Interaction | FAM168A interactions | 1.60e-04 | 142 | 39 | 4 | int:FAM168A | |
| Interaction | RIMBP2 interactions | 1.63e-04 | 10 | 39 | 2 | int:RIMBP2 | |
| Interaction | TPRX2 interactions | 1.73e-04 | 56 | 39 | 3 | int:TPRX2 | |
| Interaction | ELF5 interactions | 1.83e-04 | 147 | 39 | 4 | int:ELF5 | |
| Interaction | DRP2 interactions | 1.99e-04 | 11 | 39 | 2 | int:DRP2 | |
| Interaction | TBC1D3 interactions | 1.99e-04 | 11 | 39 | 2 | int:TBC1D3 | |
| Interaction | ARID2 interactions | 2.14e-04 | 153 | 39 | 4 | int:ARID2 | |
| Interaction | SMARCE1 interactions | 2.19e-04 | 287 | 39 | 5 | int:SMARCE1 | |
| Interaction | FLI1 interactions | 2.34e-04 | 62 | 39 | 3 | int:FLI1 | |
| Interaction | SMARCA4 interactions | 2.41e-04 | 462 | 39 | 6 | int:SMARCA4 | |
| Interaction | CLIC3 interactions | 2.46e-04 | 63 | 39 | 3 | int:CLIC3 | |
| Interaction | LHX4 interactions | 2.92e-04 | 166 | 39 | 4 | int:LHX4 | |
| Interaction | ALG13 interactions | 4.22e-04 | 183 | 39 | 4 | int:ALG13 | |
| Interaction | LHX2 interactions | 4.22e-04 | 183 | 39 | 4 | int:LHX2 | |
| Interaction | SMARCD2 interactions | 4.22e-04 | 183 | 39 | 4 | int:SMARCD2 | |
| Interaction | SS18L2 interactions | 4.27e-04 | 76 | 39 | 3 | int:SS18L2 | |
| Interaction | MEGF6 interactions | 4.30e-04 | 16 | 39 | 2 | int:MEGF6 | |
| Interaction | ATN1 interactions | 4.58e-04 | 187 | 39 | 4 | int:ATN1 | |
| Interaction | NR3C1 interactions | 4.67e-04 | 974 | 39 | 8 | int:NR3C1 | |
| Interaction | HNF1B interactions | 4.86e-04 | 190 | 39 | 4 | int:HNF1B | |
| Interaction | SMARCD1 interactions | 5.37e-04 | 349 | 39 | 5 | int:SMARCD1 | |
| Interaction | RBPMS2 interactions | 5.53e-04 | 83 | 39 | 3 | int:RBPMS2 | |
| Interaction | IRF1 interactions | 5.53e-04 | 83 | 39 | 3 | int:IRF1 | |
| Interaction | SMARCC2 interactions | 5.66e-04 | 353 | 39 | 5 | int:SMARCC2 | |
| Interaction | PAX2 interactions | 5.93e-04 | 85 | 39 | 3 | int:PAX2 | |
| Interaction | IRF4 interactions | 5.93e-04 | 85 | 39 | 3 | int:IRF4 | |
| Interaction | GSC interactions | 6.35e-04 | 87 | 39 | 3 | int:GSC | |
| Interaction | SMARCB1 interactions | 6.50e-04 | 364 | 39 | 5 | int:SMARCB1 | |
| Interaction | MORC2 interactions | 7.24e-04 | 91 | 39 | 3 | int:MORC2 | |
| Interaction | TLE3 interactions | 7.52e-04 | 376 | 39 | 5 | int:TLE3 | |
| Interaction | PCDHB14 interactions | 8.23e-04 | 22 | 39 | 2 | int:PCDHB14 | |
| Interaction | SMARCC1 interactions | 8.27e-04 | 384 | 39 | 5 | int:SMARCC1 | |
| Interaction | SMAD2 interactions | 8.37e-04 | 385 | 39 | 5 | int:SMAD2 | |
| Interaction | NUCKS1 interactions | 8.42e-04 | 220 | 39 | 4 | int:NUCKS1 | |
| Interaction | HAPSTR1 interactions | 9.45e-04 | 829 | 39 | 7 | int:HAPSTR1 | |
| Interaction | NFIX interactions | 9.46e-04 | 227 | 39 | 4 | int:NFIX | |
| Interaction | CREBBP interactions | 9.51e-04 | 599 | 39 | 6 | int:CREBBP | |
| Interaction | ING1 interactions | 1.04e-03 | 103 | 39 | 3 | int:ING1 | |
| Interaction | SIRT1 interactions | 1.13e-03 | 412 | 39 | 5 | int:SIRT1 | |
| Interaction | H4C9 interactions | 1.19e-03 | 108 | 39 | 3 | int:H4C9 | |
| Interaction | TEX13A interactions | 1.24e-03 | 27 | 39 | 2 | int:TEX13A | |
| Interaction | ETV1 interactions | 1.43e-03 | 29 | 39 | 2 | int:ETV1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.40e-19 | 149 | 41 | 11 | chr17q12 |
| Cytoband | 17q12 | 2.97e-08 | 99 | 41 | 5 | 17q12 | |
| Cytoband | Xq22 | 1.78e-04 | 22 | 41 | 2 | Xq22 | |
| Cytoband | 3q13.33 | 3.33e-04 | 30 | 41 | 2 | 3q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 4.96e-04 | 172 | 41 | 3 | chrXq22 | |
| Cytoband | Xq24 | 1.51e-03 | 64 | 41 | 2 | Xq24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq24 | 2.41e-03 | 81 | 41 | 2 | chrXq24 | |
| GeneFamily | AT-rich interaction domain containing | 1.47e-04 | 15 | 22 | 2 | 418 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.90e-04 | 17 | 22 | 2 | 486 | |
| GeneFamily | Collagens | 1.42e-03 | 46 | 22 | 2 | 490 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 5.54e-03 | 92 | 22 | 2 | 521 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 9.18e-14 | 90 | 41 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | COL4A6 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.13e-12 | 213 | 41 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | COL4A6 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.13e-12 | 213 | 41 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | COL4A6 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.52e-11 | 242 | 41 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.65e-09 | 281 | 41 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.65e-09 | 281 | 41 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.22e-09 | 320 | 41 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A6 ACTR1B TMTC2 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K KAT6A TBC1D3F | 2.18e-06 | 1466 | 41 | 13 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | ACTR1B TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K KAT6A TBC1D3F | 4.14e-06 | 1075 | 41 | 11 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | IRS1 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.29e-05 | 1049 | 41 | 10 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A6 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.13e-05 | 1153 | 41 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.61e-04 | 298 | 41 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.15e-04 | 721 | 41 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.47e-04 | 730 | 41 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 166 | 41 | 4 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 173 | 41 | 4 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-05 | 175 | 41 | 4 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 176 | 41 | 4 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.94e-05 | 193 | 41 | 4 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| Drug | khellin | 5.26e-06 | 171 | 34 | 5 | CID000003828 | |
| Drug | foscarnet | 8.78e-06 | 190 | 34 | 5 | CID000003414 | |
| Disease | neuroblastoma (is_implicated_in) | 1.25e-07 | 10 | 31 | 3 | DOID:769 (is_implicated_in) | |
| Disease | Neuroblastoma | 1.72e-07 | 47 | 31 | 4 | C0027819 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.07e-05 | 5 | 31 | 2 | C3281201 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 2.24e-05 | 7 | 31 | 2 | EFO_0020797 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 3.83e-05 | 9 | 31 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 8.27e-05 | 13 | 31 | 2 | C0265338 | |
| Disease | Adenocarcinoma Of Esophagus | 9.64e-05 | 14 | 31 | 2 | C0279628 | |
| Disease | Adenoid Cystic Carcinoma | 1.58e-04 | 100 | 31 | 3 | C0010606 | |
| Disease | Liver carcinoma | 1.72e-04 | 507 | 31 | 5 | C2239176 | |
| Disease | CCL4 measurement | 2.01e-04 | 20 | 31 | 2 | EFO_0004751 | |
| Disease | Breast Carcinoma | 2.27e-04 | 538 | 31 | 5 | C0678222 | |
| Disease | Granulomatous Slack Skin | 2.44e-04 | 22 | 31 | 2 | C0376407 | |
| Disease | Nasopharyngeal carcinoma | 2.44e-04 | 22 | 31 | 2 | C2931822 | |
| Disease | Carcinoma, Granular Cell | 2.46e-04 | 116 | 31 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.46e-04 | 116 | 31 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.46e-04 | 116 | 31 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.46e-04 | 116 | 31 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.46e-04 | 116 | 31 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 2.46e-04 | 116 | 31 | 3 | C0001418 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.67e-04 | 23 | 31 | 2 | C0079773 | |
| Disease | Sezary Syndrome | 3.69e-04 | 27 | 31 | 2 | C0036920 | |
| Disease | macrophage inflammatory protein 1b measurement | 3.92e-04 | 136 | 31 | 3 | EFO_0008219 | |
| Disease | Prostatic Neoplasms | 4.23e-04 | 616 | 31 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.23e-04 | 616 | 31 | 5 | C0376358 | |
| Disease | prostate cancer (is_marker_for) | 5.84e-04 | 156 | 31 | 3 | DOID:10283 (is_marker_for) | |
| Disease | Burkitt Lymphoma | 6.58e-04 | 36 | 31 | 2 | C0006413 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 7.73e-04 | 39 | 31 | 2 | EFO_0008298 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 8.54e-04 | 41 | 31 | 2 | C0496956 | |
| Disease | Breast adenocarcinoma | 8.54e-04 | 41 | 31 | 2 | C0858252 | |
| Disease | high grade glioma (is_implicated_in) | 8.96e-04 | 42 | 31 | 2 | DOID:3070 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MYQMLRHMSPPLGLG | 1851 | O00555 | |
| MPGMPGQSMRVGYTL | 1456 | Q14031 | |
| RMQFPMEMAAAPGRP | 1461 | Q07092 | |
| PNYVGRPKHMRVMAG | 36 | P42025 | |
| QQGMSMPDVMGRMPY | 1331 | Q8NFD5 | |
| QAPPYPGMNRTDDMM | 1556 | Q8NFD5 | |
| GPFQEMYRPSGMQMH | 1436 | Q9BXF3 | |
| MYRPSGMQMHPVQSQ | 1441 | Q9BXF3 | |
| KGPPIQFRMMTGRMR | 336 | Q96IZ5 | |
| ASMGNRPYGPNMANM | 861 | O14497 | |
| QRIPYMTGGRVMRML | 516 | Q5T848 | |
| QPASVLRPMVRGGMY | 2211 | Q9UPA5 | |
| PTMPREGRPMYQRQM | 201 | P50549 | |
| RYMKQAQALGPQMMG | 221 | Q86SU0 | |
| RRHPQRVDPNGYMMM | 651 | P35568 | |
| QQGYPMVYPGMIQMP | 816 | Q96JP2 | |
| GMNMGVNLMPTPAYN | 1896 | Q92794 | |
| MRGMYQPVAGGMQPP | 2456 | P46100 | |
| PNSYGRRPIQVMMMG | 41 | P42771 | |
| GIRPSMEMNRMIPGS | 651 | O00512 | |
| MQPMVMQGCPYTLPR | 1 | Q13474 | |
| SPMVERRMMGQRSPA | 536 | Q8N3V7 | |
| MMFDDRRGRPVGFPM | 241 | P61978 | |
| GGAAVMRPMMQPQVS | 1201 | Q9Y6Q9 | |
| LMARNMLPFMAVGQP | 196 | P0C7M4 | |
| DRAYKGMPMNIRGPM | 96 | B9A6J9 | |
| CMDRMGGLMQPPYEV | 901 | Q9Y2K9 | |
| YQRPGMSPGNRMPMA | 71 | Q92925 | |
| MMGQRPMAPYRPSQQ | 226 | O75177 | |
| DRAYKGMPMNIRGPM | 96 | A6NDS4 | |
| DRAYKGMPMNIRGPM | 96 | P0C7X1 | |
| DRAYKGMPMNIRGPM | 96 | A6NER0 | |
| GRGNMPMLCPPEYMV | 541 | Q5XPI4 | |
| MPRQFAPQSLYNMMG | 636 | Q8N394 | |
| DQAYKGMPMNIRGPM | 96 | A0A087X179 | |
| LMARNMLPFMAVGQP | 196 | Q9BQY4 | |
| DRAYKGMPMNIRGPM | 96 | A0A087WVF3 | |
| QDQRPQGQYPSMMMA | 551 | Q9C0D7 | |
| DRAYKGMPMNIRGPM | 96 | Q6DHY5 | |
| DRAYKGMPMNIRGPM | 96 | Q8IZP1 | |
| DRAYKGMPMNIRGPM | 96 | A0A087X1G2 | |
| DRAYKGMPMNIRGPM | 96 | A0A087WXS9 | |
| DRAYKGMPMNIRGPM | 96 | Q6IPX1 |